about
The association between chronic pain and obesityImplications of analgesics use in osteoporotic-related pain treatment: focus on opioidsSerum testosterone levels and mortality in men with CKD stages 3-4Methadone induces testosterone suppression in patients with opioid addiction.The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism.Depression in adolescents and young adults with cancer.Successful fertility restoration after allogeneic hematopoietic stem cell transplantation.Opioid and chronic non-cancer painIncreased Risk of Depression Recurrence After Initiation of Prescription Opioids in Noncancer Pain Patients.New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.The Role of Testosterone Supplemental Therapy in Opioid-Induced Hypogonadism: A Retrospective Pilot Analysis.Prevalence of Relative Deficiencies in Testosterone and Vitamin B12 Among Patients Referred for Chronic Orchialgia: Implications for Management.Characteristics of new depression diagnoses in patients with and without prior chronic opioid use.The influence of prescription opioid use duration and dose on development of treatment resistant depression.Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study.The importance of sexual function in men with spinal cord injuries.Low testosterone levels associated with venlafaxine use: a case reportErectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study.Testicular responses to hCG stimulation at varying doses in men with spinal cord injury.Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review
P2860
Q26800261-2920A7C1-3492-4695-831A-3F9B74BEBCB6Q28071550-B98FBE09-8923-44C1-9B61-6F206460B6F8Q34084357-CCEE2155-3EEF-4AED-8267-DFB738CEBA0AQ34085814-F6C22889-7364-48A7-9FB9-0EBA6B509B10Q35284151-F9E91ACE-C7F3-4A13-AC9C-25BD3DAE23D0Q35899456-C26D45C4-512B-4D9F-89FF-A91DF1A2310DQ36423641-8D1E76D0-3DA3-4DB9-845B-FAAAA7167664Q36663226-EA6B9DDB-3210-4304-A54F-33ABBD491622Q36961590-5E405BC6-0BD7-4672-A9B5-8CD6790827EDQ36996381-1C164E7C-D3B0-4229-8EA3-A58245B238EAQ38720725-28D4ECA2-D038-4647-A887-9ECAEBC7DE23Q38802406-D1FCBC47-7ECD-454F-B346-B977EE3F5F0BQ39052901-3D171E89-206A-46CC-98E9-0F20EDBDAF30Q39516963-F681CE06-A71A-47D3-8506-7A091CC37D69Q40416695-C2F39B23-F2D2-4F57-A3C2-0E3BEFC5CDEBQ40907687-D7BA536D-641A-4ECB-A7AD-EAE52C0A7F87Q41880170-51CD4084-E930-43F0-BBF2-2D6798F68346Q47121691-8408FFE6-FB48-4F21-BDBE-728812A35EEBQ47964271-8F06002D-74B4-4F75-87F0-3D91022BE95FQ59127218-A0395DA7-BF44-4592-B315-E89DF3E02E7E
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Opioid-induced androgen deficiency (OPIAD).
@ast
Opioid-induced androgen deficiency (OPIAD).
@en
Opioid-induced androgen deficiency
@nl
type
label
Opioid-induced androgen deficiency (OPIAD).
@ast
Opioid-induced androgen deficiency (OPIAD).
@en
Opioid-induced androgen deficiency
@nl
prefLabel
Opioid-induced androgen deficiency (OPIAD).
@ast
Opioid-induced androgen deficiency (OPIAD).
@en
Opioid-induced androgen deficiency
@nl
P1476
Opioid-induced androgen deficiency (OPIAD)
@en
P2093
Howard S Smith
Jennifer A Elliott
P304
P433
P577
2012-07-01T00:00:00Z